Analgesics - Chile

  • Chile
  • In Chile, the revenue in the Analgesics market is projected to reach €59.61m in 2024.
  • It is anticipated that the market will experience an annual growth rate of 6.17% (CAGR 2024-2029).
  • When compared to other countries worldwide, the in the United States generates the highest revenue in this market, amounting to €6,647.00m in 2024.
  • In terms of per person revenues, in Chile generates €3.03 in 2024.
  • Chile's growing demand for natural and herbal analgesics reflects a shift towards holistic healthcare practices in the OTC Pharmaceuticals market.

Key regions: Brazil, Europe, Germany, Canada, United States

 
Marché
 
Région
 
Comparaison de régions
 
Monnaie
 

Analyst Opinion

The Analgesics market in Chile has been experiencing significant growth in recent years.

Customer preferences:
Chilean consumers have shown a growing preference for over-the-counter (OTC) analgesic products. This can be attributed to several factors, including the convenience of purchasing these products without a prescription, the increasing awareness of self-care and self-medication, and the affordability of OTC analgesics compared to prescription medications. Additionally, consumers in Chile are becoming more health-conscious and are actively seeking out products that offer quick and effective relief from pain.

Trends in the market:
One of the key trends in the Analgesics market in Chile is the increasing demand for natural and herbal analgesic products. Consumers are becoming more conscious about the potential side effects of synthetic drugs and are seeking alternative options. This has led to the introduction of a wide range of natural analgesics in the market, including products made from herbal extracts and essential oils. Manufacturers are capitalizing on this trend by launching new products that cater to the growing demand for natural remedies.Another trend in the market is the rising popularity of online retail channels for purchasing analgesic products. E-commerce platforms have gained significant traction in Chile, offering consumers a convenient and hassle-free way to purchase their preferred analgesic products. The availability of a wide range of products, competitive pricing, and doorstep delivery options have contributed to the increasing adoption of online channels by consumers.

Local special circumstances:
Chile has a well-developed healthcare system, with a strong emphasis on public healthcare. However, the public healthcare system is often burdened with long waiting times and limited access to specialized services. As a result, many consumers in Chile prefer to self-medicate for minor ailments, including pain relief. This has contributed to the growth of the Analgesics market in the country, as consumers seek quick and accessible solutions for their pain management needs.

Underlying macroeconomic factors:
Chile has experienced steady economic growth in recent years, which has had a positive impact on the purchasing power of consumers. As disposable incomes increase, consumers are more willing to spend on healthcare products, including analgesics. Additionally, the aging population in Chile has also contributed to the growth of the Analgesics market, as older individuals are more likely to experience chronic pain and require regular pain management.In conclusion, the Analgesics market in Chile is witnessing significant growth, driven by customer preferences for OTC products, the rising demand for natural and herbal analgesics, the increasing popularity of online retail channels, and the local special circumstances of the healthcare system. These trends, coupled with the underlying macroeconomic factors of economic growth and an aging population, are expected to continue driving the growth of the Analgesics market in Chile in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Vue d’ensemble

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Veuillez patienter

Contact

Des questions ? Nous nous ferons un plaisir de vous aider.
Statista Locations
Contact Camille Dubois
Camille Dubois
Customer Relations

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (États-Unis)

Lun - Ven, 9:00 - 18:00 h (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asie)

Lun - Ven, 9:00 - 17:00 h (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asie)

Lun - Ven, 10:00 - 18:00 h (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Lun - Ven, 9:00 - 18:00 h (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Amérique latine)

Lun - Ven, 9:00 - 18:00 h (EST)